MRD Ready to Guide Multiple Myeloma Treatment Decisions?

Summary
(MedPage Today) -- As minimal residual disease (MRD) testing becomes increasingly important in multiple myeloma care, questions remain about whether MRD negativity should guide decisions on treatment duration and the need for stem cell transplantation...
Description from Medpagetoday.
Who is covering this
-
MRD Ready to Guide Multiple Myeloma Treatment Decisions?
(MedPage Today) -- As minimal residual disease (MRD) testing becomes increasingly important in multiple myeloma care, questions remain about whether MRD negativity should guide decisions on treatment duration and the need for stem cell transplantation...
Comments
Comments need JavaScript.